Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Immune cell therapies and immune cell engineering

Original research

Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells

Online download statistics by month:

Online download statistics by month: September 2021 to March 2024

	Abstract	Full	Pdf
Sep 2021	933	933	411
Oct 2021	404	404	157
Nov 2021	251	251	98
Dec 2021	196	199	87
Jan 2022	177	185	108
Feb 2022	89	95	54
Mar 2022	81	89	51
Apr 2022	129	138	67
May 2022	129	132	66
Jun 2022	162	164	58
Jul 2022	146	151	72
Aug 2022	144	149	69
Sep 2022	156	161	92
Oct 2022	253	256	85
Nov 2022	143	144	69
Dec 2022	97	99	37
Jan 2023	125	128	55
Feb 2023	175	175	67
Mar 2023	114	115	54
Apr 2023	100	100	42
May 2023	86	86	52
Jun 2023	59	61	31
Jul 2023	85	87	38
Aug 2023	82	84	38
Sep 2023	73	78	44
Oct 2023	88	89	51
Nov 2023	93	93	40
Dec 2023	124	124	28
Jan 2024	91	94	43
Feb 2024	66	68	47
Mar 2024	90	93	84
Total	4941	5025	2295